Drug Shortage Report for GLYCOPYRROLATE INJECTION USP

Last updated on 2025-12-04 History
Report ID 244055
Drug Identification Number 02473879
Brand name GLYCOPYRROLATE INJECTION USP
Common or Proper name GLYCOPYRROLATE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) GLYCOPYRROLATE
Strength(s) 0.2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR
Packaging size PACK OF 10 VIALS 1 mL
ATC code A03AB
ATC description DRUGS FOR FUNCTIONAL BOWEL DISORDERS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2024-12-13
Actual start date
Estimated end date 2026-02-27
Actual end date
Shortage status Actual shortage
Updated date 2025-12-04
Company comments Contract coverage confirmed as of end of November 2025.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2025-12-04 French Compare
v27 2025-12-04 English Compare
v26 2025-11-13 French Compare
v25 2025-11-13 English Compare
v24 2025-10-30 French Compare
v23 2025-10-30 English Compare
v22 2025-09-12 French Compare
v21 2025-09-12 English Compare
v20 2025-08-28 French Compare
v19 2025-08-28 English Compare
v18 2025-06-25 French Compare
v17 2025-06-25 English Compare
v16 2025-06-11 French Compare
v15 2025-06-11 English Compare
v14 2025-04-10 French Compare
v13 2025-04-10 English Compare
v12 2025-03-20 French Compare
v11 2025-03-20 English Compare
v10 2025-02-27 French Compare
v9 2025-02-27 English Compare

Showing 1 to 20 of 28